Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Continue reading...
Continue reading...
Become a Patron!
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
- Thread starter VUBot
- Start date
- Status
- Status